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In the course of our investigation to isolate the non-steroidal antiinflammatory active (NSAlA) lead molecules
from the plants, 1[(2S)-4-hydroxy-7 -hydroxymethyl-2-( l-hydroxy-l-methylethyl)-2,3-dihydro-5H-oxolo[3',2':4,sJ-
benzo [b]oxin-5-one also called as norcimifugin] has been isolated from the dichloromethane extract of rhizomes of
Cimicifuga foetida. Characterization, total synthesis and antiinflammatory activity of 1 are reported. Alkyl;
ester, carbamate, amine derivatives of 1 have been synthesized and their antiinflammatory activity assessed.
Norcimifugin displayed antiinflammatory activity in the carrageenin induced paw edema model (50.4% inhibition at
50 mg/kg, p.o.).
The rhizomes of the genus Cimieifuga Linn 1
(Ranunculaceae) have been used as an antipyretic
and an analgesic remedy in Chinese traditional
medicine. This species occurs in the temperate
Himalayas from Kumaon to Bhutan at an altitude
of 7,000-12,000 ft. Cimieifuga foetida is reported
to be an insect repellent" The rhizome of
Cimieifuga species is known to contain highly
oxygenated 9,19-cyclolanostane triterpenol
glycosides such as cimigenol xyloside,
acetylshengmanol xyloside and 24-0-
acetylhydroshengmanol xyloside, in addition to
cinnamic acid derivatives, chromones, indolinones
and other compoundsv". Norcimifugin was
previously isolated from Eranthus pinnatifida13 and
A li . . 1415 I I' f 1 fnge lea japontca '. so anon 0 rom
Cimifuga foetida has not been reported earlier.
Similarly its antiinflammatory activity is also being
reported for the first time.
Isolation procedure. The rhizomes of the
Cimieijuga Foetida plant was collected from
Kashmir, dried and extracted with methanol. The
crude extract (253 g) was passed through HP-20
column using 0-100 % methanol in water as a
gradient eluant. The active fractions came out in
75-100% methanol in water, which after
evaporation of the solvent gave a crude mixture
(142.0 g), of which 140 g were reloaded on a silica
gel column using 0-100% methanol in chloroform
"Dedicated to Mrs Rekha Singh (expired on 22nd November,
1997)
as eluting solvent. Fraction 7-14 (39.00 g) showed
the desired activity. Further purification of the
active fraction was carried out using an Ito-
multilayer coil, with the solvent system n-
hexane:ethylacetate: methanol: water (1:1:1:1).
[aqueous phase was the mobile phase and the
organic phase was the stationary phase]. The
fractions were collected at a flow rate of 1.5
mL/min. The active fractions 20-35 were
evaporated to afford 1 g of crude material, of which
0.65 g was chromatographed on an Ito-multilayer
coil using solvent system of petroleum
ether:ethylacetate:acetone:water (2: 1:2: 1). [the
stationary phase was the aqueous phase and mobile
phase the organic phase]. The fractions were
collected at flow rate of 2mL/min., of which
fractions 81-90 were found to be active and gave
0.052 g desired product. Recrystallisation of the
same gave pure norcimicifugin 1, (0.016 g)
(Figure 1). Yield from the crude extract was
0.12%.
Compound 1. Mol.formula: C15H1606; rnIz(EI):
292 (M+) was identified as norcimifugin on the
basis of its spectral data: m.p.: 208-209°C; UV A..nax
OH
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(MeOH): 226, 234, 258, 302 nm; IR(KBr): 3265,
1670, 1630, 1600 cm ': IH NMR(CDCh): 0 1.28
(s, 3H, CH3), 1.36 (s, 3H, CH3), 3.14 (d, 2H, 1=9
Hz, 3-CH2), 4.48 (s, 2H, CH20H), 4.74 (t, IH, 1=9
Hz 2-H), 6.26 (s, IH, 6-H), 6.28 (s, IH, 9-H).
Results and Discussion
For the synthesis of norcimifugin 1, 5,7-dihy-
droxy-4-oxo-4H-benzo[b ]oxin-2-ylmethyl acetate 6
was considered as the intermediate of the Judicious
choice and was synthesized in three steps from
2,4,6-trihydroxyacetophenone 216.The reaction of
6 with 3-chloro-3-methylbut-l-yne 7 (comround 7
was prepared as reported in the literatureI ) in dry
DMF at 65°C in presence of K2C03 afforded
selectively 7-0-alkylated chromone 8, which on
hydrogenation in presence of Lindlar catalyst gave
9. Claisen rearrangement 'of 9 in N,N-diethyl
aniline at 180-200°C yielded a mixture of 10 and
11 in 2: 1 ratio, which was purified through silica
gel column chromatography using a 20% ethyl
acetate in petroleum ether as an eluant.
The structures of 10 and 11 were confirmed
using Gibb's test, which was positive for
compound 11 and negative for compound 10.
Oxidation of 10 and 11 with m-
chloroperoxybenzoic acid followed by hydrolysis
with NaHC03:H20:EtOH resulted in
isonorcimifugin 12 and norcimifugin 1 respectively
in excellent yield (Scheme I).
To study the role of the alkyl chain at position-9
of norcimifugin, compound 17 was prepared.
Compound 10 was hydrogenated over 10% PdlC to
give 13, which was alkylated using 3-chloro-3-
methylbut-l-yne 7 to afford 14. Reduction of
alkyne 14 using Lindlar catalyst gave 15, which on
heating with diethylaniline gave a Claisen
rearrangement product 16. Compound 16 was
oxidized with m-chloroperoxybenzoic acid to get
an epoxide intermediate, which after treatment with
aq. NaHC03 at room temperature under went
intramolecular cyclization to give 17 (Scheme In.
To improve the antiinflammatory activity of
norcimifugin and to study the structure-activity
relationship a number of 7-substituted amino-
carbonyloxy 19, 7-0-alkylated 20, 7-arylalkyl-
carbonyloxy 21 and 7-carbonyloxymethylamino 22
derivatives were synthesized (Scheme III).
Reaction of norcimifugin 1 with alkylhalides in
presence of NaH (2.2 eq.), gave selectively 7-0-
alkylated derivatives. The reaction of aryl or alkyl
acids with 7-hydroxymethyl group of norcimifugin
in the presence of DCC and DMAP gave
selectively the corresponding ester 21. A number of
carbamates of norcimifugin 19 were synthesized by
reacting norcimifugin with diimidazolecarbonyl to
make an activated ester followed by treatment with
differently substituted amines. Norcimifugin was
reacted with bromoacetylbromide in presence of
pyridine at O°Cto give bromomethyl carbonyloxy
18, which was reacted with various amines to give
carbonyloxy methylamino substituted norcimifugin
22.
Biological activity. Modifications of 1 were
aimed to improve the pharmacological activity.
Introduction of esters, carbamates, ethers were
carried out selectively at the hydroxymethyl
position, without altering the main skeleton. All the
compounds synthesized in this series were
subjected to antiinflammatory testing in
carrageenin induced paw edema model. Some of
the compounds (listed in the Table I) showed
moderate antiinflammatory activity, however none
has shown better activity than the natural product.
Compounds 19d, 19f and 21e displayed 40-50 %
inhibition at 50 mg/kg, p.o. in the carrageenin
induced paw edema model. The rest of the
compounds has shown below 15 % inhibition at the
same concentration.
Synthetic (±) norcimifugin is half as active as the
natural molecule, on the weight basis, indicates that
only one optical isomer is active. Similarly angular
isonorcimifugin 12 is completely inactive, which
proves that, the rigeochemistry of the molecular
setup is equally important for its pharmacological
properties. Extra substitution on the aromatic ring
also did not improve its pharmacological activity as
in case of compound 17. The study indicated that
there is a very narrow window available for the
modification of norcimifugin 1 to improve
pharmacological activity.
Experimental Section
General. Melting points were recorded on a
Kofler Hot-plate apparatus and are uncorrected. IR
spectra were obtained on a Perkin-Elmer 157
spectrophotometer using KBr pellets. IH NMR
spectra were recorded on a Jeol FX 90
sf-ectrometer using TMS as an internal standard,
I C NMR spectra on a Brucker ACP-300 (chemical
shifts are expressed in ppm) and mass spectra on a
Kratos MS80 operating at 70ev. Compounds
synthesized were purified on a flash silica gel
column chromatography by using the following
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a. Me2NCOCH20Me, BF3·Et20, CH3S02CI, 110-1 lSoC. l!. HBr-AcOH, reflux.j; KOAc/DMF,
rt.!t. 3-Chloro-3-methylbut-I-yne, K2C03, DMF, 60-6SoC.~. Lindlar Cat/H2, EtOAc.
f. C6HSNEt2, ISO-160°C. g. mCPBA, NaHC03, CHCI3-H20, rt.h. NaHC03, EtOH-H20,
rt- 40°C.
Scheme I
Usual workup. Reaction mixture diluted with
water, extracted in ethyl acetate, washed with water
followed by brine. Combined organic extracts were
evaporated in vacuo to get crude residue.
5, 7:Dihydroxy-2-methoxyrnethyl-4H-benzo-
[b loxin-4-one 4. To a stirred solution of dry 2,4,6-
trihydroxyacetophenone 2 (90 g, 0.535 mole) in
dry N,N-dimethylmethoxyacetamide 3 (313.5 g,
2.676 mole) was added dropwise BF3.Et20 (303.84
gradient eluant systems: A: 0-2 % MeOHlCH2Ch;
B: 5-10 % Ethylacetate/petroleum ether; C: 5-10
% CH3CN/CH2Ch ; D: 40-50 Ethylacetate/petro-
leum ether; E: 10-40 % CH3CN/CH2Ch.
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.!!.. PdlC, H2, DMF . .!!.3-Chloro-3-methylbut-l-yne, K2C03, DMF, 50-60°C. I. Lindlar Cat.! H2
, EtOAc.
!t. PhNEt2, 200oC.~. mCPBA, NaHC03, CHCI3-H20, rt. fNaHC03, EtOH-H20, rt-50oC
g, 2.141 mole) under nitrogen and stirred for 30
min- Methanesulfonyl chloride (183.92 g, 1.606
mole) was added dropwise to the reaction mixture
at 60-65°C. After the addition was completed, the
reaction temperature was raised to ltO-lt5°C and
stirred for 30 minutes. The reaction mixture was
cooled and poured in crushed ice, then 100 mL of
cone. HCI was added and stirring continued for 1.5
hr. The separated solid was filtered , washed with
water and dried to give impure 4, which was
purified by using solvent system A to furnish white
crystalline solid (80 g, 67%). m.p. 180-81°C;
IR(KBr): 3440, 1660, 1630 em": IH
NMR(CDCh+DMSO-d6): 83.48 (s, 3H, OCH3), 4.8
(s, 2H, CH20Me), 6.16 (s, 1H, 3-H), 6.2 (d, 1H, i;
= 2 Hz, Ar-H), 6.30 (d, 1H, i;=2 Hz, Ar-H); Anal.
Calcd. f-or:CIIHIO05.H20, C, 55.00; H, 4.99.
Found: C, 55.26; H, 4.75%.
Scheme II
2-Bromomethyl-S, 7-dihydroxy-4H-benzo[b]-
oxin-4-one S. A solution of 4 (80 g, 0.360 mole) in
HBr-AcOH (33%, 800 mL) was refluxed for 36 hr
TLC showed no starting material. The reaction
mixture was cooled, poured in to cold water, the
precipitated solid was filtered, washed with water
and dried to give TLC pure 5 as a dark brown solid
(85 g), which was used in next step without further
purification. IR(KBr): 3500, 1650, 1620 cm': IH
NMR (CDCh+DMSO-d6): 0 4.48 (s, 2H, CH2Br),
6.20 (d, 1H, i:= 2 Hz, Ar-H), 6.32 (d, 1H, i;= 2
Hz, Ar-H ), 6.40 (s, 1H, 3-H); EI-MS (m/z): 270
and 272.
5, 7-Dihydroxy-4-oxo-4H-benzo[b ]oxin-2-yl-
methyl acetate 6. To a stirred solution of 5 (85 g)
in dry DMF (350 mL) was added fused potassium
acetate (121.65 g, 1.24 mole) and stirring continued
at room temperature for 15 min. DMF was
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a . Im2CO, HNR1 R2, CH2C12 rt. b. NaH, RX (X=haJide), DMF, OOC-rt. s. RCOOH, DCC, DMAP,,
CH2C12, rt !t. BrCOCH2Br, Pyridine, ovc. ~. HNR1 R2, CH2C12, rt.
Scbeme III
removed in vacuo, the solid obtained was triturated
with water, filtered, washed with water and dried to
furnish 6, which was purified by using solvent
system A (58.9 g, 65.4%). m.p.: 155-56°C; IR
(KBr): 3440, 1660, 1630 em"; IH NMR (CDCh):
o 2.16 (s, 3H, OCOCH3), 4.88 (s, 2H, CH20Ac),
6.12 (s, IH, 3-H), 6.28 (2xd, 2H, i:= 2 Hz, 6 & 8-
ArH); EI-MS (rn/z); 250; Anal. Calcd. for
C12HIO06, C, 57.60, H,4.02. Found, C: 57.22, H,
4.36%.
7-(1,1- Dimethyl-2-propynyloxy )-5-hydroxy-4-
oxo-4H-benzo[b ]oxin-2-ylmethyl acetate 8. To a
mixture of 6 (2 g, 0.008 mole) and dry K2C03
(1.656 g, 0.012 mole) in dry DMF (6.25 mL) a
freshly prepared 3-chloro-3-methylbut-l-yne 7
(3.28 g, 0.032 mole) was added and the reaction
stirred at 60-65~C for 12 hr. The solvent was
removed in vacuo, poured in cold water (50 mL)
and acidified with dilute acetic acid. After usual
work-up, the crude residue was purified by using
solvent system B to afford pure 8 (1.65 g, 65%);
m.p. 137-38°C; IR (KBr): 1755, 1670, 1630 cm':
IH NMR (CDCh): 1.76 (s, 6H, 2xCH3), 2.2 (s, 3H,
OCOCH3), 2.68 (s, IH, C=CH) , 4.96 (s, 2H,
CH20Ae), 6.16 (s, 1H, 3-CH), 6.60 (d, IH, 1m = 2
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IH, ArOH); Anal. Calcd. for C17HI606, C, 64.56,
H, 5.09. Found, C, 64.46, H, 5.12%.
7-(1,1- Dimethylallyloxy )-5-hydroxy-4-oxo-4H-
benzo[b ]oxin-2-ylmethyl acetate 9. Compound 8
(74 g, 0.2339 mole) was hydrogenated over Lindlar
catalyst (7 g) with quinoline (70 mL) in
ethyl acetate (1000 mL) at 40 psi for 10 min. The
catalyst was filtered and ethyl acetate solution was
washed with dil. HCl followed by brine. The
organic layer was dried over Na2S04 and
concentrated. The crude residue was purified by
using solvent system B to afford pure 9 (70 g,
94%); m.p. 132°C; !R(KBr): 3450, 1740, 1660,
1585 cm ": IH NMR(CDCh): 8 1.56 (s, 6H,
2xCH3), 2.2 (s, 3H, OCOCH3), 4.94 (s, 2H,
CH20Ac), 5.1 (m, IH, =CH), 5.26 (m, 2H, =CH2),
5.98 (s, IH, 3-H), 6.18 (d, IH, 1 = 2.1 Hz, Ar-H),
6.46 (d, 2H, 1 = 2.1 Hz, ArH), 12.34 (s, IH, Ar-
OH); Anal. Calcd. for C17HIS06, C, 64.14, H, 5.69.
Found, C, 64.16, H, 5.87%.
5, 7-Dihydroxy-8-(3-methyl-2-butenyl)-4-oxo-
4H-benzo[b]oxin-2-ylmethyl acetate 10. 5,7-
Dihydroxy -6-(3-methyl- 2-butenyl)-4-oxo-4H-
benzo[b ]oxin-2-ylmethyl acetate 11: Compound 9
(55g, 0.01728 mole) was taken in N, N-diethyl-
aniline (300 mL) and heated at 150-60°C for 10
min. TLC after 10 min showed no starting
compound and two new compounds were formed.
After usual work-up, the crude residue was purified
by using solvent system A to yield 10 (38 g, 69%),
and 11 (16.5 g, 30%).
Compound 10: m.p.: 209-21O°C; IR(KBr):
3200, 1740, 1620 cm ': IH NMR(CDCh+ DMSO-
d6): 8 1.68 (s, 3H, CH3) 1.8 (s, 3H, CH3), 2.2 (s,
3H, OCOCH3), 3.36 (d, 2H, 1=6.73 Hz, CH2), 4.98
(s, 2H, CH20Ac), 5.18 (m, IH, =CH), 6.16 (s, lH,
Ar:H) , 6.36 (s, lH, Ar-H), 10.06 (s, IH, ArOH),
12.42 (s, IH, ArOH); Anal. Calcd. forC17Hls06.1I2
H20, C, 62.37, H, 5.8. Found: C, 62.43; H, 5.9%.
Compound 11: m.p.: 212-13°C; !R(KBr): 3150,
1715, 1620 cm'"; IH NMR(CDCh+ DMSO-d6): 8
1.7 (s, 3H, CH3) 1.82 (s, 3H, CH3), 2.2 (s, 3H,
OCOCH,), 3.34 (d, 2H, 1 = 7.51 Hz, CH2), 4.92 (s,
2H, CH20Ac), 5.24 (m, IH, =CH), 6.14 (s, IH, Ar-
H), 6.4 (s, IH, Ar-H), 9.66 (s, 1H, Ar-OH), 12.66
(s, IH, Ar-OH); Anal. Calcd. for C17HIS06, C,
64.14, H, 5.69. Found: C, 64.39, H, 5.75%.
4-Hydroxy-7-hydroxymethyl-2-(I-hydroxy-l-
methylethyl)-2,3-dihydro-5H-oxolo [3',2' :4,5]-
benzo[b ]oxin-5-one (Norcimifugin) 1. To a stirred
solution of 11 (11g, 34.6 mmole) in chlororform
(300 mL) was added sodium bicarbonate (3.3 g),
water (7 mL) followed by 3-chloroperoxybenzoic
acid (9.35 g, 11.7 g of 80%, 54.2 mmole). The
reaction mixture was stirred for 20 min. The
chloroform solution was washed with aq. NaHC03
followed by brine, dried over Na2S04 and
concentrated to give epoxide intermediate. To the
above residue was added ethanol (550 mL), a
solution of NaHC03 (3.96 g, 11.9 mrnole) in water
(550 mL) and reaction mixture was stirred at 40-
50°C for 24 hr. It was then concentrated,
neutralized with dil AcOH. After usual work-up,
the crude residue was purified by using solvent
system C to yield norcimifugin 1 (9.1 g, 90%),
m.p. 197-98°C; !R(KBr): 3250, 1725, 1670, 1625
cm'"; IH NMR(CDCh+DMSO-d6): 8 1.26 (s, 3H,
CH3), 1.32 (s, 3H, CH3), 3.12 (d, 2H, 1 = 8.81 Hz,
3-CH2), 4.44 (s, 2H, CH20H), 4.72 (t, IH, 1 = 8.81
Hz, 2-CH), 6.24 (s, IH, Ar-H), 6.27 (s, IH, Ar-H),
12.92 (s, IH, Ar-OH); Anal. Calcd. for C15H1606,
C, 61.63, H, 5.51. Found: C, 61.60, H, 5.74%.
5-Hydroxy-2- hydroxymethyl-8-(I-hydroxy-1-
methylethyl)-8, 9-dihydro-4H-oxolo [2',3':5,6]-
benzo[b ]oxin-4-one 12. To a stirred solution of 10
(1.25 g, 3.9 mmole) in chlororform (30 mL) was
added sodium bicarbonate (0.179 g,), water (0.6
mL) followed by 3-chloroperoxybenzoic acid
(1.0856 g of 80%, 7.9 mmole). The reaction
mixture was stirred for 20 min. The CHCh solution
was washed' with aq. NaHC03 followed by brine,
dried over Na2S04 and concentrated to give
epoxide intermediate. To the above residue was
added ethanol (60 mL), a solution of NaHC03
(0.45 g, 5.4 mmole) in water (60 mL) and reaction
mixture was stirred at 40-50°C for 8 hr. It was then
concentrated, neutralized with dil AcOH. After
usual work-up, the crude residue was purified by
using solvent system D to yield 12 (0.78 g, 69%
yield). m.p. 173°C; IR(KBr): 3380, 1670, 1625
cm"; IH NMR(CDCh+CD30D):8 1.26 (s, 3H,
CH3), 1.36 (s, 3H, CH3), 3.16 (d, 2H, 1 = 8.94 Hz,
CH2), 4.44 (s, 2H, CH2), 4.72 (t, 1H, 1 = 8.94 Hz,
OCH), 6.2 (s, 2H, Ar-H); Anal. Calcd. for:
CIsHI606 1/2 H20, C, 59.79, H, 5.68. Found, C,
59.95, H, 5.91 %.
5, 7-Dihydroxy -8-isopentyl-4-oxo-4H -benzo-
[b ]oxin-2-ylmethyl acetate 13. A solution of 10
(2 g, 6.2 mmole) in DMF (20 rnL) was
hydrogenated over 10% Pd-C (0.2 g) at 40 psi for 5
hr. The reaction mixture was filtered, filtrate
concentrated and the residue was passed through a
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silica gel column eluting with solvent system C to
give a solid material 13 (1.75 g, 87%). m.p. 162-
63°C; IH NMR (CDCh+DMSO-d6): s 0.96 (d, 6H,
1 = 5.7 Hz, 2xCH3), 1.24-1.56 (m, 3H, CH2 and
CH), 2.17 (s, 3H, COCH3), 2.68 (m, 2H, benzylic-
CH2), 4.98 (s, 2H, CH20Ac), 6.16 (s, IH, Ar-H),
6.32 (s, IH, Ar-H), 10.22 (s, IH, ArOH), 12.42 (s,
IH, Ar-OH); Anal. Calcd. for C17H2006; C, 63.74;
H, 6.29. Found: C, 63.57, H, 6.35%.
7-(1,1- Dimethyl-2-propynyloxy )-5-hydroxy-8-
isopeniyl-4-oxo- 4H-benzo[b ]oxin-2-ylmethyl
acetate 14. To a stirred solution of 13 (0.9g, 2.81
mmole) in dry DMF (5 mL) was added anhydrous
K2C03 (0.582 g, 4.21 mmole), 3-chloro-3-
methylbut-l-yne 7 (2.882 g, 28.1 mmole) and KI
(0.05 g). Reaction mixture was stirred at 50-60°C
for 15 hr. The reaction mixture was neutralized
with dilute acetic acid. After usual work-up, the
crude residue was purified by using solvent system
B to afford compound 14 (0.6g, 69% based on the
recovery of starting material). m.p. 58°C; !R(KBr):
. 3280, 1760, 1670, 1630, 1605 ern"; IH NMR
(CDCh): s 0.94 (d, 6H, 1 = 6.22 Hz, 2xCH3), 1.24-
1.52 (m, 3H, CH2 and CH), 1.72 (s, 6H, 2xCH3),
2.16 (s, 3H, COCH3), 2.64 (t, 2H, 1 = 8.81 Hz,
CH2), 2.68 (s, IH, =C-H), 4.94 (s, 2H, CH20Ac),
6.16 (s, IH, Ar-H), 7.08 (s, IH, Ar-H) , 12.43 (s,
IH, Ar-OH); Anal. Calcd. for C22H2606,C, 68.37,
H, 6.78. Found C, 68.02, H, 6.67%.
7-(1, 1-Dimethylallyloxy )-5-hydroxy-8-isopen-
tyl-4-oxo-4H-benzo[b ]oxin-2-ylmethyl acetate
15. A solution of 14 (0.625 g, 1.61 mmole) in ethyl
acetate (10 mL) was hydrogenated over Lindlar
catalyst (0.06 g) at 40 psi for 10 min The catalyst
was filtered and ethyl acetate solution was washed
with dil. HCI followed by brine. The organic layer
was dried over Na2S04 and was concentrated. The
crude residue was purified by using solvent system
B to give pure 15 (0.475 g, 75.6%). m.p. 55°C;
IR,(KBr): 3440, 1740, 1650, 1615 cm'": IH
NMR(CDCh): s 0.98 (d, 6H, 2xCH3), 1.4 (m, 3H,
CH2 and CH), 1.6 (s, 6H, 2xCH3), 2.2 (s, 3H,
OCOCH3), 2.68 (t, 2H, 1=8.06 Hz, benzylic-Cll-),
4.98 (s, 2H, CH20Ac), 5.22 (dd, IH, 1=13 & 2.60
Hz, =CH), 5.3 (m, 2H, =CH), 6.18 (s, IH, 6-CH),
6.58 (s, IH, 3-CH), 12.39 (s, IH, ArOH); Anal.




acetate 16. Compound 15 (0.35 g, 0.901 mmole) in
N,N-diethylaniline (I mL) was heated at 150-
160°C for 10 min. The reaction mixture after· 10
min shows no starting compound. After usual
work-up, the crude residue was purified by using
solvent system B to furnish pure 16 (0.3 g, 85.7 %).
m.p. 140°C; !R(KBr): 3220, 1765, 1660, 1625
ern"; IH NMR(CDCh): s l.16 (d, 6H, J = 6.22 Hz,
2xCH3), 1.46 (m, 3H, CH2 and CH), 1.79-1.9 (2xd,
6H, 1 = 5.44 Hz, =C(CH3)2), 2.2 (s, 3H, COCH3),
2.68 (t, 2H, 1 = 7.77 Hz, benzylic-Crl-), 3.48 (d,
2H, 1 = 9.07 Hz, CH2), 4.98 (s, 2H, CH20Ac), 5.24
(m, IH, =CH), 6.2 (s, IH, Ar-H), 12.82 (s, IH, Ar-
OH); Anal. Calcd. for C22H2S06,C, 68.02, H, 7.26.
Found: C, 67.67, H, 7.23%.
4-Hydroxy-7-hydroxymethyl-2- (1-hydroxy-1-
methylethyl)-9-isopentyl-2, 3-dihydro-5H-oxolo-
[3',2':4,5]benzo[b]oxin-5-one 17. To a stirred
solution of 16 (0.225 g, 0.579 mmole) in
chloroform (10 mL) was added NaHC03 (0.194 g,
2.32 mmole), water (0.5 mL) followed by 3-
chloroperoxybenzoic acid (0.15 g, 0.868 mmole) .
The chloroform solution was washed with aq.
NaHC03 followed by brine, dried over Na2S04 and
was concentrated to give epoxide intermediate. To
the above residue was added ethanol (60 mL), a
solution of NaHC03 (0.487 g, 15.8 mmole) in
water (60 mL) and reaction mixture was stirred at
40-50°C for 6 hr. TLC showed no starting
compound. After usual work up, the crude
compound was purified by using solvent system C
to furnish pure 17 (0.19 g, 90.5%). m.p. 171-72°C;
IR(KBr): 3450, 1675, 1630 em"; IH NMR(CDCh+
DMSO-d6): 80.76 (d, 6H, 1 = 7.2 Hz, 2xCH3), 1.1
(s, 6H, 2xCH3), 1.26 (m, 3H, CH2 and CH), 2.48 (t,
2H, 1 = 6.48 Hz, CH2), 2.99 (d, 2H, 1 = 8.55 Hz, 3-
CH2), 4.3 (s, 2H, CH20H), 4.56 (t, IH, 1 = 8.55 Hz,
2-CH), 5..12 (br, IH, OH), 6.15 (s, IH, 6-CH ),
12.66 (s, IH, ArOH); Anal. Calcd. for C2oH2606,C,
66.28, H, 7.23. Found: C, 66.59, H, 7.45%.
4-Hydroxy-2-(1-hydroxy- 1-methylethyl)-5-
oxo-2,3-dihydro-5H-oxolo[3' ,2' :4,5] benzo [b]-
oxin-7-ylmethyl-2-bromoacetate 18. To a stirred
suspension of norcimifugin 1 (1.2 g, 3.1042
mmole) in dry dichloromethane (50 mL), dry
pyridine (0.486 g, 6.156 mmole) was added. The
contents of the flask were cooled to 0-5°C and
bromoacetyl bromide (0.99 g, 4.9 mmole) was
added slowly. The reaction was stirred at 0-5°C for
30 min. Reaction mixture was washed with dil. HCI
followed by brine, dried over Na2S04 and
concentrated. The crude residue was purified by
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using solvent system C to give 18 (1.289 g, 77%).
m.p. 134-35°C; IR(KBr): 3400, 1760, 1675, 1640
cm'; IH NMR (CDCh): s 1.26 (s, 3H, CH3), 1.36
(s, 3H, CH3), 3.1 (d, 2H, J = 8.85 Hz, 3-CH2), 3.92
(s, 2H, CH2Br), 4.74 (t, 1H, J = 8.85 Hz, 2-CH),
5.02 (s, 2H, 7-CH2), 6.2 (s, 1H, Ar-H), 6.28 (s, 1H,
Ar-H), 12.63 (s, 1H, Ar-OH); Anal. Calcd. for
C17H17Br07; C, 49.41, H. 4.14, Br, 19.33. Found:
C, 49.55, H, 4.13, Br, 19.01%.
General procedure for Norcimifugin
derivatives. (Scheme-Iff)
(A) Carbamates: To a stirred solution of
norcimifugin 1 (1 eq) in dry dichloromethane (10
rnL) was added l,l/-carbonyldiimidazole (1.5 eq)
and stirring continued for 30 min. Amine (1.5 eq)
was added to the above reaction mixture and stirred
for another one hour. After 1 hr reaction mixture
shows no starting compound. After usual work-up,
the crude residue was purified by using solvent
system E to afford compound 19, yield: 69-93 %.
(B) 7-0-Alkylderivatives: To a suspension of
sodium hydride (3 eq) in dry DMF (5 rnL) was
added norcimifugin 1 (1 eq) and stirred at O°C for
30 min. After 30 min alkylhalide (1.2 eq) was
added to the above reaction and continued stirring
at room temperature for another 30 min. Reaction
mixture was acidified with 5 % AcOH at O°c.
After usual work-up, the crude residue was purified
by using solvent system C to give 20, yeild: 38-
49%.
(C) Esters: To a stirred solution of acid (1.1 eq)
in dry drichloromethane (10 rnL) was added DCC
(1.5 eq) and stirring continued for 10 min. After 10
min norcimifugin 1 (1eq), followed by DMAP (10
mg) was added to the above reaction mixture and
reaction continued stirring for 1 hr. Diethylether
was added to the reaction mixture to precipitate the
dicyclohexyl urea which is formed during the
reaction and it was filtered. The filtrate was washed
with aq. NaHC03 solution followed by brine, dried
over Na2S04 and concentrated. The crude residue
was purified by using solvent system C to give
21,yield: 60-98%.
(D) Carbonyloxymethyl substituted amines.
To a stirred solution of 4-hydroxy-2-( I-hydroxy-l-
methylethyl)-5-oxo-2, 3-dihydro-5H-oxolo-[3',2':
4,5]benzo[b [oxin-? -ylmethyl-Z-bromoacetate 18
(1 eq) in dry dichloromethane (5 rnL) was added
dry amine (2.4 eq) and stirred at 20-25°C for 2 hr.
After usual work-up, the crude residue was purified
by using solvent system E to give 22, yeild 85-93
%. Hydrochloride salts were made in the usual
manner and crystallized from MeOH-EhO mixture,
if necessary.
All the derivatives which are synthesized are
listed in Table 1.
Acknowledgement
Authors are thankful to the Dr Virbala Shah and
Dr B S Kalakoti for supplying plant extracts. We
are also thankful to analytical group for providing
spectral and analytical data of the compounds.
References
1 Koeda M & Aoki Y, Chem.Pharm.Bull, 43,1995,771
2 Chopra & Badhwar, Indian J. Agri. Sci, 10, 1940, 16
3 Sakurai N, Koeda M, Aoki Y & Nagai M,
Chem.Pharm.Bull, 43, 1995, 1475
4 Kusano A, Shimizu K, Idoji M, Shibano M, Minoura &
Kusano G, Chem.Pharm.Bull 43, 1995, 279
5 Kusano A, Shibano M, Minoura & Kusano G,
Chem.Pharm.Bull, 43,1995, 1167
6 Katoda S, Li J X, Tanaka K & Namba T, Tetrahedron, 51,
1995,1143
7 Li J X, Katoda S, Pu X F & Namba T, Tetrahedron Lett,
35,1994,4575
8 Kusano Y & Nozoe S, Heterocycles, 20,1983,1951
9 Kondo Y & Takemoto T, Chem.Pharm.Bull, 20, 1972,
1940
10 Corsano S, Mellor J H & Ourisson G, J.Chem.Soc,
Chem.Commun, 1965, 185 (struct)
11 (a)Takemoto T & Kusano G, Yakugaku Zasshi, 88, 1968,
623
(b)Takemoto T, Kusano G & Yamamoto N, Yakugaku
Zasshi, 87,1967, 1489
(c)Takemoto T, Kusano G & Kawahara M, Yakugaku
Zasshi, 90, 1970, 64
12 Kusano G, Yakugaku Zasshi, 95,1975,113
13 Wada H, Gaino M & Saito S, Phytochemistry, 13, 1974,
297
14 Kirtany J K, Paknikar S K & Chatterjee A, Indian J Chem,
11,1973,505
15 Chatterjee A & Dutta S, Indian J Chem, 6,1968,415
16 Bass R J; J.Chem.Soc, Chem.Commun, 2, 1976,78
17 Hennion G F & Armand P Boisselle, J Org Chem, 26,
1961, 725
